Market Overview

Hospira, Q Core Medical Sign Int'l Distribution Deal for Sapphire System

Related HSP
Hospira Granted Temporary Restraining Order Against FDA, Shares Pop Higher
BioScrip Posts Wider-than-Expected Q2 Loss on Poor Margins

Hospira, Inc. (NYSE: HSP), the world's leading provider of injectable drugs and infusion technologies, and Q Core Medical, Ltd., an innovation leader in infusion delivery systems, today announced that the companies have entered into a distribution agreement for the Q Core Sapphire™ multi-therapy infusion system. Through the arrangement, Hospira will have exclusive rights to market and distribute Sapphire -- a compact and lightweight infusion device system frequently used in ambulatory and hospital settings -- in more than 60 key markets across Europe, Asia and The Americas. The agreement also enables Hospira to collaborate with Q Core for distribution of its product development pipeline.

Posted-In: News Contracts

 

Related Articles (HSP)

Around the Web, We're Loving...

Get Benzinga's Newsletters